A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.

Exclusion Criteria

• •Any medical disorder, condition, or history that would impair participation.
• •* Known hypersensitivity to the study drug or its excipients.
• •* Known disorders with increased bleeding risk or known congenital/acquired coagulation disorders.
• •* Use of prescription drugs, over-the-counter drugs, or herbal products within 14 days or 5 half-lives before the study.
• •* Clinically relevant findings in the ECG, such as a QTcF over 450 msec.
• •* Systolic blood pressure below 90 mmHg or above 140 mmHg at screening and admission.
• •* Diastolic blood pressure below 40 mmHg or above 90 mmHg at screening and admission.
• •* Positive results for Hepatitis B, Hepatitis C, or HIV.
• •* Positive drug screening, alcohol breath test, or urine cotinine test.
• •* Clinically relevant deviations of the screened laboratory parameters from reference ranges at the screening visit.
• •* Positive pregnancy test.
• •* Donation of blood or plasma within specified timeframes before the study.
• •* Lack of compliance with lifestyle restrictions (e.g., alcohol, specific foods, strenuous activity).
• •* Previous participation in this or another clinical study within a specified timeframe.